Our Pricing

Understanding Your 1mg Wegovy Starting Dose

Obtaining a 1mg Wegovy prescription online UK is the first step in your medically supervised weight management journey. At Cured Pharmacy, our UK-registered prescribers provide free clinical consultations under 3 minutes, with transparent pricing from £79.00 and 100% discreet packaging for genuine UK-licensed Wegovy injections.

Why 1mg Wegovy Is the Starting Dose

The 1mg dose represents the initial four-week phase of Wegovy treatment, designed to allow your body to adjust gradually to semaglutide [1]. This cautious dose escalation approach significantly reduces the likelihood of gastrointestinal side effects whilst your system adapts to the medication's appetite-regulating mechanisms.

Clinical protocols established in the STEP trial programme demonstrated that starting at 0.25mg for four weeks, then increasing to 1mg, optimises both tolerability and long-term adherence [1]. Patients who follow this graduated dosing schedule are substantially more likely to reach therapeutic doses and achieve meaningful weight reduction over 68 weeks of treatment.

Your UK prescriber will assess whether the 1mg starting dose is appropriate based on your medical history, current medications, and weight management goals. Subject to clinical approval, you'll receive clear instructions on injection technique and what to expect during your first month of treatment.

How Wegovy 1mg Works in Your Body

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your intestines produce after eating [2]. Even at the 1mg starting dose, semaglutide begins slowing gastric emptying, which prolongs feelings of fullness and reduces appetite between meals.

The medication also acts on areas of the brain that regulate appetite and food intake, particularly the hypothalamus [2]. In the STEP-1 trial, participants using semaglutide achieved an average 14.9% body weight reduction over 68 weeks compared to 2.4% with placebo, when combined with lifestyle interventions including reduced-calorie diet and increased physical activity [1].

What to Expect During Your First Month

During the initial 1mg phase, most patients notice subtle changes in appetite rather than dramatic weight loss. This is intentional — the starting dose allows your body to adapt whilst minimising side effects such as nausea or digestive discomfort. Significant weight reduction typically occurs as you progress to higher therapeutic doses of 1.7mg and 2.4mg in subsequent months, subject to prescriber guidance and tolerability assessment.

The Complete Wegovy Dose Escalation Schedule

Wegovy follows a structured five-month escalation protocol, with each dose maintained for four weeks before increasing [3]. You begin with 0.25mg weekly for month one, progress to 0.5mg in month two, then 1mg in month three, followed by 1.7mg in month four, and finally reach the maintenance dose of 2.4mg weekly from month five onwards.

This graduated approach is not arbitrary — MHRA licensing conditions specify this exact schedule based on clinical trial data showing optimal balance between efficacy and tolerability [3]. Your prescriber may adjust this timeline if you experience persistent side effects or have specific medical considerations that warrant a slower progression.

When Dose Adjustments May Be Necessary

Some patients require extended time at the 1mg dose before progressing to 1.7mg, particularly if experiencing ongoing nausea or gastrointestinal symptoms. Your UK prescriber will monitor your response through follow-up consultations and may recommend remaining at a lower dose for an additional four weeks. This individualised approach ensures you achieve therapeutic benefit whilst maintaining treatment adherence and quality of life.

Getting Your 1mg Wegovy Prescription Online UK Through Cured Pharmacy

Our streamlined online consultation takes under 3 minutes and is reviewed by UK-registered prescribers including our superintendent pharmacist Tarun Kumar (GPhC 2233073). You'll answer medical history questions covering cardiovascular health, current medications, previous weight loss attempts, and any contraindications to GLP-1 therapy.

If clinically appropriate, your prescription is issued the same day and dispensed from our GPhC-registered pharmacy (9012511). Wegovy is available from £79.00 with transparent upfront pricing shown before you complete your consultation — no hidden fees or subscription charges. All medications are genuine UK-licensed products supplied in discreet, unmarked packaging with next-day delivery options available.

Prescription-only medicines like Wegovy legally require assessment by a UK prescriber before dispensing. Our clinical team evaluates each application individually, and approval is never guaranteed. If Wegovy is not suitable for you, our prescribers will explain why and may suggest alternative weight management options where clinically appropriate.

Common Side Effects at the 1mg Starting Dose

The most frequently reported side effects during the 1mg phase include nausea, diarrhoea, constipation, and abdominal discomfort [1]. In the STEP trials, these gastrointestinal effects were typically mild to moderate and diminished over subsequent weeks as the body adapted to semaglutide.

Approximately 7% of trial participants discontinued treatment due to adverse effects, most commonly gastrointestinal symptoms [1]. To minimise discomfort, eat smaller portions, avoid high-fat meals, stay well-hydrated, and inject at a consistent time each week. If side effects become severe or persistent, contact your prescriber before your next dose — do not simply stop treatment without medical guidance.

When to Seek Medical Attention

Seek immediate medical help if you experience severe abdominal pain that does not resolve, persistent vomiting preventing fluid intake, signs of pancreatitis (severe upper abdominal pain radiating to your back), or symptoms of thyroid tumours (lump in neck, difficulty swallowing, persistent hoarseness). Whilst serious adverse events are rare, early recognition and intervention are essential for patient safety. Always inform your prescriber of any concerning symptoms during treatment.

Maximising Results with Lifestyle Modifications

Wegovy is licensed as an adjunct to reduced-calorie diet and increased physical activity, not as monotherapy [3]. Clinical trial participants followed structured lifestyle programmes including 500-calorie daily deficit and at least 150 minutes of moderate physical activity weekly. Those who adhered to both medication and lifestyle interventions achieved significantly greater weight reduction than either approach alone.

Your prescriber may recommend working with a registered dietitian or weight management programme to optimise nutritional intake whilst taking Wegovy. Focus on protein-rich foods to preserve lean muscle mass during weight loss, prioritise fibre for digestive health, and establish sustainable eating patterns you can maintain long-term. The medication provides a physiological advantage by reducing appetite and cravings, but lasting success requires behavioural change alongside pharmacotherapy.

Regular monitoring of body weight, waist circumference, and metabolic markers (blood pressure, HbA1c if diabetic, lipid profile) helps track progress and identify any adjustments needed to your treatment plan. Your prescriber will schedule follow-up consultations to assess response to therapy and determine whether dose escalation is appropriate as you progress beyond the 1mg starting phase.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Knudsen, L. B., & Lau, J. (2019). The Discovery and Development of Liraglutide and Semaglutide. Frontiers in Endocrinology, 10, 155. https://doi.org/10.3389/fendo.2019.00155
3. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. https://products.mhra.gov.uk/

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.